Radiosurgery system begins UK trials
This article was originally published in Clinica
Executive Summary
Trials of a new system for delivering low-energy radiation therapy directly to tumours have begun in the UK following successful Phase I trials in the US. The Photon Radiosurgery System (PRS), developed by US company Photoelectron, comprises a 3 mm-diameter, 100 mm-long needle which is inserted into the tumour, delivering X-rays from a battery-powered source. Initially configured for treating brain tumours, the system works with a stereotactic frame and the needle is passed through the track left by a biopsy cannula.